Circular RNAs in Oral Squamous Cell Carcinoma: A Systematic Review of Emerging Diagnostic and Prognostic Biomarkers [0.03%]
Omar Abdul Jabbar Abdul Qader,Asmaa Uthman,Walid Elsayed et al.
Omar Abdul Jabbar Abdul Qader et al.
CircRNAs exhibit strong potential as diagnostic and prognostic biomarkers in OSCC, particularly in liquid biopsy applications. However, heterogeneity, small sample sizes, and lack of multicenter validation limit immediate clinical translation.
Single-Blood-Draw-Based Screening of Cancer Histotypes via Homologous Adhesion between Tumor Extracellular Vesicles and Bionic Microspheres [0.03%]
Jing-Lian Su,Zi-Wei Yang,Jia-Jing Li et al.
Jing-Lian Su et al.
Precise cancer diagnosis boosts survival rates, but liquid biopsy struggles to identify the tumor histotype from a single blood draw.
A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR Mutations [0.03%]
Cornelia Kropf-Sanchen,Nikolaj Frost,Jonas Kuon et al.
Cornelia Kropf-Sanchen et al.
The feasibility of dual inhibition strategies and personalized monitoring through liquid biopsy remains underexplored in real-world clinical practice....In 1 patient, molecular recurrence in liquid biopsy preceded clinical and radiologic progression, underscoring the potential of this approach for early detection of therapeutic resistance....Personalized ddPCR-based liquid biopsy is a promising tool for real-time, non-invasive monitoring of treatment response and resistance evolution.
Multicenter Study
Clinical lung cancer. 2026 May;27(4):97-107.e1. DOI:10.1016/j.cllc.2026.03.005 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study [0.03%]
Kerstin Michalski,Theo Lorenzini,Tim Jedamzik et al.
Kerstin Michalski et al.
Background: Prostate cancer is the second leading cause of cancer-related mortality in men worldwide. Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) has emerged as a theranostic strategy for ...
Sajad Ehtiati,Behnam Ravanbakhsh,Hassan Ghasemi et al.
Sajad Ehtiati et al.
This review summarizes recent advances in the biological functions, clinical relevance, and translational potential of exosomal lncRNAs in esophageal cancer, highlighting their emerging value in liquid biopsy and targeted therapeutic strategies.
Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan [0.03%]
SungGi Chi,Ikuko N Motoike,Takao Fujisawa et al.
SungGi Chi et al.
These findings define the landscape of CHIP in the Japanese population and clarify its relationship to CH detected by cancer-focused liquid biopsy assays.
CD44+ and CD133+ Extracellular Vesicles as Future Potential Targets in Gastrointestinal Tumor [0.03%]
Cristina Pizzulli,Beatrice Menicacci,Margherita Parrini et al.
Cristina Pizzulli et al.
Despite ongoing challenges in EV isolation and standardization, EVs positive for stemness markers show great potential as liquid biopsy analytes for noninvasive disease monitoring, prognostic evaluation, and patient stratification.
Case report: immunotherapy response in pancreatic cancer after MSI-H emerged post-chemotherapy [0.03%]
Kareem Gharaybeh,Karim Khalidi,Sana Al-Sukhun
Kareem Gharaybeh
Upon clinical and biochemical progression, liquid biopsy using Guardant360 CDx revealed MSI-H status and a TP53 H214fs mutation, both absent in her initial molecular profile....It also highlights clinically relevant discrepancies in MSI detection between liquid biopsy platforms and supports the role of immunotherapy in selected patients with evolving molecular features.
Linfan Qi,Hui Cai
Linfan Qi
Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor [0.03%]
Yukari Adachi,Takeru Matsuda,Sachiko Inubushi et al.
Yukari Adachi et al.
Conclusion: Serum CD9+ CD63+ and CD9+ CD147+ EV subsets decreased after CRC surgery, supporting their potential utility as minimally invasive liquid biopsy biomarkers of postoperative tumor burden.
耗时 0.11816 秒，为您在
49758847
条记录里面共找到 7022 篇文章 [XML]